CN103275187B - 一种镇痛肽fi及其基因和应用 - Google Patents
一种镇痛肽fi及其基因和应用 Download PDFInfo
- Publication number
- CN103275187B CN103275187B CN201310236447.4A CN201310236447A CN103275187B CN 103275187 B CN103275187 B CN 103275187B CN 201310236447 A CN201310236447 A CN 201310236447A CN 103275187 B CN103275187 B CN 103275187B
- Authority
- CN
- China
- Prior art keywords
- analgesic
- peptide
- mouse
- analgesic peptide
- analgesia peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract description 6
- 101500007657 Crotalus durissus terrificus Crotoxin chain gamma Proteins 0.000 title abstract 7
- 230000000202 analgesic effect Effects 0.000 claims abstract description 23
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 54
- 230000036592 analgesia Effects 0.000 claims description 49
- 208000002193 Pain Diseases 0.000 abstract description 22
- 230000036407 pain Effects 0.000 abstract description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract description 10
- 238000002474 experimental method Methods 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 229940035676 analgesics Drugs 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 34
- 239000000243 solution Substances 0.000 description 13
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000002504 physiological saline solution Substances 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 208000000114 Pain Threshold Diseases 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 7
- 230000037040 pain threshold Effects 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000003187 abdominal effect Effects 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000581650 Ivesia Species 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000008176 lyophilized powder Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229960005181 morphine Drugs 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001560072 Dryophytes japonicus Species 0.000 description 2
- 101150090405 Fi gene Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000004084 narcotic analgesic agent Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000037816 tissue injury Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 1
- 241000143437 Aciculosporium take Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000340668 Bombina maxima Species 0.000 description 1
- 241001415440 Bufo gargarizans Species 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000149140 Fejervarya limnocharis Species 0.000 description 1
- 241000270878 Hyla Species 0.000 description 1
- 241000356178 Hyla simplex Species 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108010088350 Lactate Dehydrogenase 5 Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000003840 Opioid Receptors Human genes 0.000 description 1
- 108090000137 Opioid Receptors Proteins 0.000 description 1
- 241000270959 Pelophylax nigromaculatus Species 0.000 description 1
- APXXVISUHOLGEE-ILWGZMRPSA-N Phe-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=CC=C4)N)C(=O)O APXXVISUHOLGEE-ILWGZMRPSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 241000149142 Sylvirana guentheri Species 0.000 description 1
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001618 algogenic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000013373 clone screening Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000010429 evolutionary process Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Description
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310236447.4A CN103275187B (zh) | 2013-06-14 | 2013-06-14 | 一种镇痛肽fi及其基因和应用 |
PCT/CN2013/084555 WO2014198095A1 (zh) | 2013-06-14 | 2013-09-29 | 镇痛肽fi及其基因和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310236447.4A CN103275187B (zh) | 2013-06-14 | 2013-06-14 | 一种镇痛肽fi及其基因和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103275187A CN103275187A (zh) | 2013-09-04 |
CN103275187B true CN103275187B (zh) | 2014-10-29 |
Family
ID=49057828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310236447.4A Active CN103275187B (zh) | 2013-06-14 | 2013-06-14 | 一种镇痛肽fi及其基因和应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103275187B (zh) |
WO (1) | WO2014198095A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
RU2541127C1 (ru) * | 2013-11-15 | 2015-02-10 | Закрытое акционерное общество "Институт экспериментальной фармакологии" | Анальгетическое средство пептидной структуры на основе ундекапептида, содержащего d-октааргининовый вектор |
CN105732789A (zh) * | 2016-03-03 | 2016-07-06 | 中国科学院昆明动物研究所 | 森林山蛭镇痛肽mh2620及其基因和应用 |
CN108840927B (zh) * | 2018-06-06 | 2022-07-29 | 湖南生达生物科技有限公司 | 弹性蛋白酶抑制剂lnsp-i及其应用 |
CN109021073B (zh) * | 2018-08-30 | 2021-09-24 | 陕西师范大学 | 秦岭雨蛙镇痛肽ht2的改造体ht12及其应用 |
CN112521457B (zh) * | 2020-12-29 | 2022-03-01 | 潍坊医学院 | 一种分离自华蟾素注射液的镇痛肽ci118及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1324367A (zh) * | 1998-08-28 | 2001-11-28 | 迈洛斯公司 | 环状前塞波素衍生肽及其应用 |
CN101845099A (zh) * | 2010-04-23 | 2010-09-29 | 中国药科大学 | 一种长效镇痛肽及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10039063A1 (de) * | 2000-08-10 | 2002-02-21 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitung mit einem Gehalt an Cyclodextrinen zur Beseitigung von Sebum |
CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
-
2013
- 2013-06-14 CN CN201310236447.4A patent/CN103275187B/zh active Active
- 2013-09-29 WO PCT/CN2013/084555 patent/WO2014198095A1/zh active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1324367A (zh) * | 1998-08-28 | 2001-11-28 | 迈洛斯公司 | 环状前塞波素衍生肽及其应用 |
CN101845099A (zh) * | 2010-04-23 | 2010-09-29 | 中国药科大学 | 一种长效镇痛肽及其应用 |
Non-Patent Citations (3)
Title |
---|
Jing Wu et al..Proteomic Analysis of Skin Defensive Factors of Tree Frog Hyla simplex.《Journal of Proteome Research》.2011,第10卷4230-4240. |
Proteomic Analysis of Skin Defensive Factors of Tree Frog Hyla simplex;Jing Wu et al.;《Journal of Proteome Research》;20110711;第10卷;4230-4240 * |
仇缀百等.蛙皮啡肽和雨蛙啡肽:二种新型的镇痛肽.《国外医学.药学分册》.1983,123-124. * |
Also Published As
Publication number | Publication date |
---|---|
CN103275187A (zh) | 2013-09-04 |
WO2014198095A1 (zh) | 2014-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103275187B (zh) | 一种镇痛肽fi及其基因和应用 | |
CN100427502C (zh) | 抗肿瘤寡肽及其制备方法和应用 | |
CN105131084B (zh) | 基于内吗啡肽2或Biphalin的棕榈酰化修饰的阿片肽类似物及其合成和应用 | |
CN101240033B (zh) | 一种促胰岛素分泌肽与人血清白蛋白的融合蛋白及其制备方法 | |
CN105732789A (zh) | 森林山蛭镇痛肽mh2620及其基因和应用 | |
CN101003574B (zh) | 长效降血糖肽的重组表达及其在糖尿病治疗药物中的应用 | |
CN1526725A (zh) | 抗肿瘤多肽及其应用 | |
CN101041692A (zh) | 蝎镇痛抗菌活性肽及其制备方法 | |
CN107614512A (zh) | 用以治疗和/或预防自体免疫疾病和发炎疾病的短合成肽 | |
CN101848927B (zh) | 镇痛化合物 | |
CN104031135A (zh) | 树蛙防御肽PopuDef及其基因和应用 | |
CN102861317B (zh) | 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用 | |
CN102250217A (zh) | 华南雨蛙促皮肤损伤修复多肽及其基因和应用 | |
CN109320591A (zh) | 一种多肽oa-gl12及其应用 | |
CN103641889B (zh) | 一种降糖肽及其药物用途 | |
WO2022184163A1 (zh) | 改性九肽及其制备方法和应用 | |
CN113880915B (zh) | 用于修复黏膜损伤或皮肤创伤的多肽及其应用 | |
CN101220089A (zh) | 中国南海信号芋螺神经毒素基因Lt3.1及其应用 | |
CN108840927B (zh) | 弹性蛋白酶抑制剂lnsp-i及其应用 | |
CN101602796B (zh) | 一种含硒活性多肽及其制备方法与应用 | |
CN101205251A (zh) | 中国南海信号芋螺神经毒素基因Lt3.2及其应用 | |
CN102796176B (zh) | 一种昆嵛林蛙抗菌肽Kunyuenin及其制备和应用 | |
CN101182529A (zh) | 一种融合基因以及基因工程菌及其制备和应用 | |
CN101041691A (zh) | 中国南海信号芋螺神经毒素基因lt5.4及其应用 | |
CN108976287A (zh) | 一类阿片和神经肽ff受体多靶点分子bn-9的二硫键环化类似物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 610017 No. 88 South Park Road, Feng Wan Industrial Park, Chengdu hi tech Zone, Sichuan, China Applicant after: SICHUAN HETAI SYNLIGHT BIOTECHNOLOGY Co.,Ltd. Applicant after: KUNMING INSTITUTE OF ZOOLOGY CHINESE ACADEMY OF SCIENCES Address before: 610017 No. 88 South Park Road, Feng Wan Industrial Park, Chengdu hi tech Zone, Sichuan, China Applicant before: SICHUAN KELUN XINGUANG BIOLOGICAL SCIENCE AND TECHNOLOGY DEVELOPMENT Co.,Ltd. Applicant before: KUNMING INSTITUTE OF ZOOLOGY CHINESE ACADEMY OF SCIENCES |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SICHUAN KELUN XINGUANG BIOTECHNOLOGY DEVELOPMENT CO., LTD. TO: SICHUAN HETAI XINGUANG BIOTECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230713 Address after: No. 88 Keyuan South Road, Fengjiawan Industrial Park, High tech Zone, Chengdu, Sichuan, 610095 Patentee after: SICHUAN HETAI SYNLIGHT BIOTECHNOLOGY Co.,Ltd. Address before: 610017 No. 88 Keyuan South Road, fengjiawan Industrial Park, high tech Zone, Chengdu, Sichuan Province Patentee before: SICHUAN HETAI SYNLIGHT BIOTECHNOLOGY Co.,Ltd. Patentee before: KUNMING INSTITUTE OF ZOOLOGY CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230914 Address after: No. 57, Building 124, No.16 Jiu, Changle West Road, Xincheng District, Xi'an City, Shaanxi Province, 710032 Patentee after: Du Yanjun Address before: No. 88 Keyuan South Road, Fengjiawan Industrial Park, High tech Zone, Chengdu, Sichuan, 610095 Patentee before: SICHUAN HETAI SYNLIGHT BIOTECHNOLOGY Co.,Ltd. |